Baolingbao Biology Co.,Ltd. (SHE:002286)
China
· Delayed Price · Currency is CNY 10.63
+0.07 (0.66%)
Mar 9, 2026, 3:04 PM CST
Baolingbao Biology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,045 | 2,729 | 3,011 | 3,380 | 5,028 | 4,210 | Upgrade
|
| Market Cap Growth | 41.72% | -9.36% | -10.92% | -32.78% | 19.45% | 89.37% | Upgrade
|
| Enterprise Value | 3,978 | 2,816 | 3,117 | 3,446 | 4,715 | 3,911 | Upgrade
|
| Last Close Price | 10.63 | 7.35 | 7.94 | 8.80 | 13.01 | 10.91 | Upgrade
|
| PE Ratio | 27.22 | 24.55 | 55.79 | 25.38 | 24.94 | 84.42 | Upgrade
|
| Forward PE | - | 46.25 | 46.25 | 46.25 | 46.25 | 46.25 | Upgrade
|
| PS Ratio | 1.50 | 1.14 | 1.19 | 1.25 | 1.82 | 2.05 | Upgrade
|
| PB Ratio | 1.84 | 1.34 | 1.52 | 1.69 | 2.77 | 2.63 | Upgrade
|
| P/TBV Ratio | 1.94 | 1.42 | 1.62 | 1.80 | 2.99 | 2.87 | Upgrade
|
| P/FCF Ratio | 39.52 | 46.42 | 23.15 | - | 44.33 | 15.79 | Upgrade
|
| P/OCF Ratio | 13.07 | 10.97 | 10.67 | 109.66 | 24.38 | 10.57 | Upgrade
|
| EV/Sales Ratio | 1.48 | 1.17 | 1.24 | 1.27 | 1.71 | 1.90 | Upgrade
|
| EV/EBITDA Ratio | 13.60 | 10.75 | 17.55 | 13.36 | 14.83 | 25.79 | Upgrade
|
| EV/EBIT Ratio | 23.04 | 19.60 | 52.14 | 22.01 | 22.14 | 70.64 | Upgrade
|
| EV/FCF Ratio | 38.86 | 47.90 | 23.97 | - | 41.58 | 14.67 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.14 | 0.15 | 0.26 | 0.23 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.61 | 1.07 | 1.67 | 1.97 | 1.30 | 1.62 | Upgrade
|
| Debt / FCF Ratio | 1.75 | 4.81 | 2.34 | - | 3.63 | 0.92 | Upgrade
|
| Net Debt / Equity Ratio | -0.03 | 0.01 | 0.03 | 0.07 | -0.15 | -0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.23 | 0.11 | 0.35 | 0.55 | -0.88 | -1.58 | Upgrade
|
| Net Debt / FCF Ratio | -0.66 | 0.47 | 0.47 | -0.63 | -2.47 | -0.90 | Upgrade
|
| Asset Turnover | 1.00 | 0.90 | 0.89 | 0.90 | 0.98 | 0.80 | Upgrade
|
| Inventory Turnover | 9.00 | 7.49 | 7.58 | 7.75 | 9.56 | 9.29 | Upgrade
|
| Quick Ratio | 1.12 | 0.88 | 0.87 | 0.83 | 0.89 | 0.81 | Upgrade
|
| Current Ratio | 1.83 | 1.41 | 1.36 | 1.31 | 1.17 | 1.05 | Upgrade
|
| Return on Equity (ROE) | 6.80% | 5.52% | 2.71% | 6.98% | 11.81% | 3.15% | Upgrade
|
| Return on Assets (ROA) | 3.99% | 3.37% | 1.32% | 3.24% | 4.72% | 1.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.77% | 5.92% | 2.37% | 7.24% | 12.54% | 3.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.70% | 6.80% | 2.90% | 7.00% | 11.20% | 3.30% | Upgrade
|
| Earnings Yield | 3.56% | 4.07% | 1.79% | 3.94% | 4.01% | 1.19% | Upgrade
|
| FCF Yield | 2.53% | 2.15% | 4.32% | -6.62% | 2.26% | 6.33% | Upgrade
|
| Dividend Yield | 1.14% | 1.29% | 1.01% | 0.91% | 0.46% | 0.55% | Upgrade
|
| Payout Ratio | 32.25% | 49.76% | 92.20% | 39.43% | 19.32% | 48.76% | Upgrade
|
| Buyback Yield / Dilution | -4.48% | -2.99% | 2.74% | 0.91% | -4.81% | -1.08% | Upgrade
|
| Total Shareholder Return | -3.34% | -1.69% | 3.74% | 1.81% | -4.35% | -0.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.